Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Neoplasms 3Osteosarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Pathologic Complete Response 1Ovarian Carcinosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Hodgkin Disease 1Hepatoblastoma 1Hemangiosarcoma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

pembrolizumab 5Specimen Handling 5Nivolumab 5Cyclophosphamide 5Magnetic Resonance Spectroscopy 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Cisplatin 3sargramostim 2fludarabine 2cabozantinib 2aflibercept 2X-Rays 2Stem Cell Transplantation 2Sirolimus 2Paclitaxel 2Mesna 2Melphalan 2Irinotecan 2Ipilimumab 2Ifosfamide 2Fluorouracil 2Fluorodeoxyglucose F18 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Doxorubicin 2Cryosurgery 2Busulfan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × dostarlimab × Sarcoma × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡